Skip to content

Covista

US · CVSA #2249 by market cap Listed 1970
109.13 -6.38 -5.52%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 13 in the most recent period (2026/Q3).
  • Total institutional ownership rose 8.5 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
112.38% +8.53pp
Institutions
477 +13
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund100.63%
Hedge Fund5.76%
Public Company2.76%
Individual/Insider2.64%
Government Pension Fund1.33%
Private Company0.76%
VC/PE Fund0.54%
Insurance Company0.31%
Family Office/Trust0.13%

Top holders as of 2026-09-30

BlackRock 15.47% · 5.15M sh
FMR 12.89% · 4.29M sh
Vanguard Portfolio Management, LLC 6.82% · 2.27M sh
Dimensional Fund Advisors 5.58% · 1.85M sh
Ariel Investments, LLC 5.33% · 1.77M sh
Vanguard Capital Management, LLC 4.44% · 1.48M sh
State Street Global Advisors 4.13% · 1.37M sh
Capital Research 2.83% · 940.94K sh
Geode Capital Management, LLC 2.65% · 881.83K sh
Wellington Management Group 2.41% · 802.06K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 25 sells

NameRoleStake
Stephen Beard Chairperson & CEO 1.29%
Michael Malafronte Lead Independent Director 0.40%
Robert Phelan Senior Vice President 0.15%
Lisa Wardell Director 0.14%
Michael Betz Chief Growth & Innovation Officer, Senior VP and President of Walden University 0.09%
Douglas Beck Senior VP of Institutional Support Services, General Counsel & Corporate Secretary 0.09%
Karen Cox Former President of Chamberlain University 0.08%
Evan Trent Former President of Adtalem Elevate 0.06%
Kenneth Phelan Independent Director 0.06%
Georgette Kiser Independent Director 0.05%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-11 William Burke Independent Director Sale to Issuer -362 $119.00
2026-11-11 Michael Malafronte Lead Independent Director Sale to Issuer -487 $119.00
2026-11-11 Kenneth Phelan Independent Director Sale to Issuer -363 $119.00
2026-11-11 Donna Hrinak Independent Director Sale to Issuer -318 $119.00
2026-11-11 Emily Chiu Independent Director Sale to Issuer -110 $119.00
2026-11-11 Betty Vandenbosch Independent Director Sale to Issuer -390 $119.00
2026-11-11 Scott Liles Chief Strategy & Performance Officer and President of Medical and Veterinary Sale to Issuer -350 $119.00
2026-11-11 Michael Betz Chief Growth & Innovation Officer, Senior VP and President of Walden University Sale to Issuer -838 $119.00
2026-11-11 Douglas Beck Senior VP of Institutional Support Services, General Counsel & Corporate Secretary Sale to Issuer -314 $119.00
2026-11-11 Georgette Kiser Independent Director Sale to Issuer -391 $119.00
2026-11-11 Robert Phelan Senior Vice President Sale to Issuer -629 $119.00
2026-11-11 Manjunath Gangadharan Vice President Sale to Issuer -93 $119.00
2026-11-11 Sara Hill Chief Human Resources Officer Sale to Issuer -254 $119.00
2026-11-11 William Krehbiel Independent Director Sale to Issuer -390 $119.00
2026-11-11 Megan Noel Senior VP & Chief Corporate Affairs Officer Sale to Issuer -329 $119.00
2026-11-11 Leslie Storms Independent Director Sale to Issuer -85 $119.00
2026-11-10 William Burke Independent Director Other Acquisition +1,255 $119.55
2026-11-10 Michael Malafronte Lead Independent Director Other Acquisition +1,255 $119.55
2026-11-10 Kenneth Phelan Independent Director Other Acquisition +1,255 $119.55
2026-11-10 Donna Hrinak Independent Director Other Acquisition +1,255 $119.55

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Covista discussion 0 comments

Add a comment